Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey

Introduction Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with a global prevalence of 20%-40%. Approximately 40%-60% of patients with type 2 diabetes mellitus (DM2) experience NAFLD; out of which 20%-40% cases may have higher severity. Due to the scarcity of ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Chandan, Tripathy, Debasmita, Swain, Surendranath, Sudhakaran, Navin, Uthansingh, Kanishka, Mallick, Pradeep, Pati, Girish K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192310/
https://www.ncbi.nlm.nih.gov/pubmed/34123670
http://dx.doi.org/10.7759/cureus.14974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192310/
https://www.ncbi.nlm.nih.gov/pubmed/34123670
http://dx.doi.org/10.7759/cureus.14974

Ejemplares similares